Document:

First Amendment to the Loan and Security Agreement

 Exhibit 10.1 
 FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT 
 THIS FIRST AMENDMENT TO
LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of June 26, 2012, is entered into by and between MARLIN RECEIVABLES CORP., a Nevada corporation (“Borrower”), MARLIN LEASING CORPORATION, a
Delaware corporation (“Originator” or “Servicer”), and MARLIN BUSINESS SERVICES CORP., a Pennsylvania corporation (“Parent”), and WELLS FARGO CAPITAL FINANCE, LLC, a Delaware limited
liability company formerly known as Wells Fargo Foothill, LLC (“Lender”). 
 W I T N E S S E T H:

 WHEREAS, pursuant to the Loan and Security Agreement dated as of October 9, 2009 (as amended or modified from time
to time, the “Existing Loan Agreement”) between Borrower, Servicer, Parent and Lender, Lender has committed to making loans and certain financial accommodations available to Borrower; and 

WHEREAS, the parties hereto have agreed to amend the Existing Loan Agreement as set forth herein. 

NOW, THEREFORE, in consideration of the agreements herein contained and other good and valuable consideration, the parties hereby agree
as follows: 
 PART I 
 DEFINITIONS 
 1.1 Certain Definitions. Unless otherwise defined herein or
the context otherwise requires, the following term used in this Amendment, including its preamble and recitals, has the following meaning: 
 “Amended Loan Agreement” means the Existing Loan Agreement as amended hereby. 
 1.2 Other Definitions. Unless otherwise defined herein or the context otherwise requires, terms used in this Amendment, including its preamble and recitals, have the meanings provided in the
Amended Loan Agreement. 
 PART II 
 AMENDMENTS TO EXISTING LOAN AGREEMENT 
 2.1 Amendment to Section 1.
Section 1 of the Existing Loan Agreement is amended by deleting the defined term “Applicable Margin” in its entirety and replacing it with the following: 

“Applicable Margin” means two and three-quarters percent (2.75%) per annum. 

2.2 Amendment to Section 1. Section 1 of the Existing Loan Agreement is amended by deleting the defined term
“Base LIBOR Rate” in its entirety and replacing it with the following: 
 “Base LIBOR
Rate” means, for a calendar month, the rate per annum, determined by Lender in accordance with its customary procedures, and utilizing such electronic or other quotation sources as it considers appropriate (rounded upwards, if necessary, to
the next 1/100%), to be the rate at which Dollar deposits (for delivery on the first day of such calendar month or, if such day is not a Business Day, on the preceding Business Day) in the amount of $1,000,000 are offered to major banks in the
London interbank market on or about 11:00 a.m. (London time) two (2) Business Days prior to the first day of such calendar month, for a term of three (3) months, which determination shall be conclusive in the absence of manifest error.

 2.3 Amendment to Section 1. Section 1 of the Existing Loan Agreement is
amended by adding the following new defined term, “Commitment Termination Date”, in appropriate alphabetical order: 
 “Commitment Termination Date” means the earliest of (a) October 9, 2014, (b) the date of the termination of this Agreement by Borrower in accordance with
Section 3.6, and (c) the date of the termination of this Agreement by Lender in accordance with Section 9.1 upon the occurrence and during the continuation of an Event of Default. 

2.4 Amendment to Section 1. Section 1 of the Existing Loan Agreement is amended by deleting clauses (s), (cc), (ee),
(ll), (mm) and (nn) of the defined term “Eligible Lease” and replacing such clauses with the following: 
 (s) each Lease with respect to which the Account Debtor is the United States or any department, agency, or instrumentality of the United States; 

(cc) [RESERVED]. 
 (ee) that portion of the Net Investment in each Lease that has an original term greater than 63 months, but not greater than 72 months, which, when added to the Net Investment in all other such Leases
that are not excluded by other items of this definition and not excluded by this item (ee), exceeds three percent (3%) of the Preliminary Total Eligible Leases; 

(ll) (i) that portion of the aggregate Net Investment in all Leases covering property that is included in an Equipment
Type other than copiers, not excluded by other items of this definition, which exceeds ten percent (10%) of the Preliminary Total Eligible Leases, and (ii) that portion of the aggregate Net Investment in all Leases covering property that
is included in the Equipment Type of copiers, not excluded by other items of this definition, which exceeds forty percent (40%) of the Preliminary Total Eligible Leases; 

(mm) that portion of the aggregate Net Investment in all Leases with respect to which the Account Debtor is any state of
the United States, or any municipality or other political subdivision thereof, or of any department, agency, public corporation or other instrumentality thereof, not excluded by other items of this definition, which exceeds five percent (5%) of
the Preliminary Total Eligible Leases; 
 (nn) [RESERVED]; and 

2.5 Amendment to Section 1. Section 1 of the Existing Loan Agreement is amended by deleting the defined term
“Fee Letter” in its entirety and replacing it with the following: 
 “Fee
Letter” means that certain amended and restated fee letter, dated as of June 26, 2012, between Borrower and Lender, in form and substance satisfactory to Lender. 
 2.6 Amendment to Section 1. Section 1 of the Existing Loan Agreement is amended by deleting the defined term “Maximum Revolver Amount” in its entirety and replacing it
with the following: 
 “Maximum Revolver Amount” means $75,000,000 between the Closing Date and
the Commitment Termination Date, and $0 on and after the Commitment Termination Date. 

  
 2 

 2.7 Amendment to Section 1. Section 1 of the Existing Loan Agreement is
amended by adding the following new defined term, “Parent Leverage Ratio”, in appropriate alphabetical order: 
 “Parent Leverage Ratio” means, as of any date of determination, the ratio of (a) the outstanding amount of all Indebtedness, to (b) Tangible Net Worth as of such date, in each
case as determined on a consolidated basis for Parent and its Subsidiaries. 
 2.8 Amendment to Section 1.
Section 1 of the Existing Loan Agreement is amended by deleting the defined term “Permitted Disposition” in its entirety and replacing it with the following: 

“Permitted Disposition” means (a) a sale or other disposition of Equipment that is substantially
worn, damaged, or obsolete in the ordinary course of business, (b) a sale of Inventory (including repossessed Leased Equipment) to a buyer in the ordinary course of business, (c) the use or transfer of money or Cash Equivalents in a manner
that is not prohibited by the terms of this Agreement or the other Loan Documents, (d) sales or exchanges of Leases to Originator or to Servicer in connection with a repurchase or substitution transaction that is otherwise required or permitted
under Section 4.11, the Purchase and Contribution Agreement or the Servicing Agreement so long as (i) Originator or Servicer, as applicable, has deposited the Repurchase Price in the Lockbox Account or assigned substitute Leases to
Borrower having a Net Investment amount that is at least equivalent to such Repurchase Price to Borrower, and (ii) Servicer and Borrower have provided a Borrowing Base Certificate that reports on the status of the Borrowing Base both before and
after giving effect to such repurchase or substitution, or (e) the sale of a Lease to any Person so long as (i) such sale is without recourse to Borrower, (ii) in the case of any sale by Borrower, such sale is for a cash purchase
price of not less than the Net Investment in such Lease and the proceeds of such sale are paid to the Lender for application to the outstanding Obligations in accordance with the provisions hereof, and (iii) in the case of any sale to any
Securitization Subsidiary, (A) Borrower shall have received Lender’s consent to such sale, and (B) immediately after giving effect to such sale, the ratio of (1) the aggregate Contract Balance Remaining for Borrower Leases in the
Borrower Portfolio with respect to which one or more scheduled payments is unpaid for more than 30 days past the date such payment became due and payable according to the original terms of such Lease or, if applicable, as amended in accordance with
the Required Procedures (“Past Due Leases”) to (2) the aggregate Contract Balance Remaining for all Leases in the Borrower Portfolio, is not greater than such ratio immediately prior to giving effect to such sale. 

2.9 Amendment to Section 1. Section 1 of the Existing Loan Agreement is amended by adding the following new defined
term, “Unused Line Fee Percentage”, in appropriate alphabetical order: 
 “Unused Line
Fee Percentage” means, for any calendar quarter (or portion thereof, as applicable), (1) one percent (1.0%) in the case of any calendar quarter (or portion thereof, as applicable) with respect to which the average Daily Balance of
Advances that were outstanding during such calendar quarter (or portion thereof, as applicable) was less than or equal to $25,000,000, and (2) one-half of one percent (0.50%) in the case of any calendar quarter (or portion thereof, as
applicable) with respect to which the average Daily Balance of Advances that were outstanding during such calendar quarter (or portion thereof, as applicable) was greater than $25,000,000. 

  
 3 

 2.10 Amendment to Section 2.1. Section 2.1 of the Existing Loan Agreement
is amended by deleting such Section and replacing it with the following: 
 2.1 Revolver Advances.

 (a) Subject to the terms and conditions of this Agreement, Lender agrees to make advances (each an
“Advance,” and collectively, the “Advances”) to Borrower prior to the Commitment Termination Date in an amount at any one time outstanding not to exceed an amount equal to the lesser of (i) the Maximum
Revolver Amount, or (ii) the Borrowing Base. 
 (b) Anything to the contrary in this Section 2.1
notwithstanding, Lender shall have the right to establish reserves in such amounts, and with respect to such matters, as Lender in its Permitted Discretion shall deem necessary or appropriate, against the Borrowing Base, including reserves with
respect to (i) sums that Borrower is required to pay (such as taxes, assessments, insurance premiums, or, in the case of leased assets, rents or other amounts payable under such leases) to comply with any provision of this Agreement or any
other Loan Document that either (A) have not been paid by the applicable due date or (B) if not yet due and payable, Lender reasonably believes will not be paid by the applicable due date, and (ii) amounts owing by Borrower or its
Subsidiaries to any Person to the extent secured by a Lien on, or trust over, any of the Collateral (other than any existing Permitted Lien set forth on Schedule P-1 which is specifically identified thereon as entitled to have priority over
the Lender’s Liens), which Lien or trust, as determined in the Permitted Discretion of Lender, likely would have a priority superior to the Lender’s Liens (such as Liens or trusts in favor of landlords, warehousemen, carriers, mechanics,
materialmen, laborers, or suppliers, or Liens or trusts for ad valorem, excise, sales, or other taxes where given priority under Applicable Laws) in and to such item of the Collateral. 

(c) Lender shall have no obligation to make additional Advances hereunder to the extent such additional Advances would
cause the Revolver Usage to exceed the Maximum Revolver Amount. At no time shall the Revolver Usage exceed the Maximum Revolver Amount. 
 (d) Lender shall have no obligation to make an Advance hereunder prior to the satisfaction of each of the conditions precedent to such Advance, including without limitation the conditions set forth in
Section 3.3 hereof. Amounts borrowed pursuant to this Section 2.1 may be repaid and, subject to the terms and conditions of this Agreement, reborrowed at any time prior to the Commitment Termination Date. 

2.11 Amendment to Section 2.10. Section 2.10 of the Existing Loan Agreement is amended by deleting such Section and
replacing it with the following: 
 2.10 Fees. Borrower shall pay to Lender the following fees and
charges, which fees and charges shall be non-refundable when paid (irrespective of whether this Agreement is terminated thereafter): 
 (a) Fee Letter Fees and Charges. As and when due and payable under the terms of the Fee Letter, Borrower shall pay to Lender the fees and charges set forth in the Fee Letter; 

(b) Unused Line Fee. An unused line fee shall be calculated and be due and payable as follows: on the first day of
each calendar quarter, commencing on the first day of the first calendar quarter following the Closing Date, and on the Commitment Termination Date, Borrower shall pay to Lender an amount equal to the Unused Line Fee Percentage per annum times
the amount by which (i) the Maximum Revolver Amount exceeds (ii) the greater of (A) the average Daily Balance of Advances that were outstanding during the immediately preceding calendar quarter (or portion thereof on and
after the Closing Date, as applicable) and (B) $15,000,000; and 

  
 4 

 (c) Minimum Funding Charge. From and after the Closing Date, through
and including the Commitment Termination Date, a minimum funding charge shall be calculated and be due and payable as follows: on the first day of each calendar quarter, commencing on April 1, 2010, and on the Commitment Termination Date,
Borrower shall pay to Lender an amount equal to (i) the effective interest rate applicable hereunder during the immediately preceding calendar quarter times (ii) the amount, if any, by which (A) $15,000,000 exceeds (B) the
average Daily Balance of Advances that were outstanding during the immediately preceding calendar quarter (or portion thereof from and after the Closing Date and prior to the Commitment Termination Date); provided, that in no event shall
interest be charged, contracted for, collected or retained in excess of the maximum nonusurious amount determined in accordance with Applicable Laws. 
 2.12 Amendment to Section 3.4. Section 3.4 of the Existing Loan Agreement is amended by deleting such Section and replacing it with the following: 

3.4 Term. This Agreement shall continue in full force and effect for a term commencing on the Closing Date
and ending on October 9, 2015 (the “Maturity Date”). Notwithstanding the foregoing or any other provision of this Agreement or any other Loan Document, Lender’s obligations to make Advances (or otherwise extend credit)
under this Agreement shall terminate on the Commitment Termination Date. 
 2.13 Amendment to Section 7.10.
Section 7.10 of the Existing Loan Agreement is amended by deleting such Section and replacing it with the following: 
 7.10 Restricted Payments. Make any Restricted Payment; provided, however, that so long as the Commitment Termination Date has not occurred, no Default or Event of Default shall
have occurred and be continuing or would occur as a result thereof, and Lender shall have received the financial statements required by Section 6.3(a) for the most recently completed calendar month for which financial statements are due
hereunder, then Borrower may make dividends, distributions, or payments with respect to redemptions to holders of Stock of Borrower, provided, that, in each case on a pro forma basis, after giving effect to any such payment and any Advance made or
other Indebtedness incurred in connection therewith, (a) Borrower shall be in compliance with the financial covenants set forth in Section 7.17 (measured as if the making of any such payment and incurrence of such Advance or other
Indebtedness had occurred on the last day of the most recently completed calendar month for which financial statements are due hereunder), (b) Availability is at least $1,000,000, and (c) on or prior to the date of each such payment,
Borrower shall have delivered to Lender, in form and detail reasonably satisfactory to Lender, a certification by an Executive Officer of Borrower that, immediately after giving effect to such payment and any Advance made or other Indebtedness
incurred in connection therewith, (i) no Default or Event of Default shall have occurred and be continuing and (ii) Borrower shall be in pro forma compliance with the requirements of clauses (a) and (b). 

2.14 Amendment to Section 7.18(a). Section 7.18 of the Existing Loan Agreement is amended by deleting subsection
(a) thereof and replacing such subsection with the following: 
 (a) Maximum Parent Leverage Ratio.
Parent shall not permit the Parent Leverage Ratio on the last day of any calendar quarter to exceed 5.5 to 1.0. 

  
 5 

 PART III 
 CONDITIONS TO EFFECTIVENESS OF PART II 
 3.1 First Amendment Effective
Date. Part II of this Amendment shall be and become effective as of June 26, 2012, subject to the conditions set forth in this Part III having been satisfied (it being understood and agreed that the remainder of this Amendment shall be
effective upon the execution and delivery hereof by the parties hereto). 
 3.2 Conditions to Effectiveness. The
effectiveness of this Amendment is conditioned upon the satisfaction of the following conditions precedent, in each case on terms reasonably acceptable to Lender: 

(a) Lender shall have received two fully executed counterparts of this Amendment and the Fee Letter; 

(b) Lender shall have received (i) payment of the $200,000 closing fee set forth in the Fee Letter as being due and
payable on the effective date of this Amendment, and (ii) payment for all of Lender’s reimbursable costs and expenses incurred in connection herewith (to the extent invoiced); and 

(c) the representations and warranties contained in Section 5 of the Existing Loan Agreement (after giving effect to
the amendments contained herein) are true and correct in all material respects, except to the extent any such representations or warranties refer back to a specific earlier date, and then only as of such date, and no Default or Event of Default
exists under the Existing Loan Agreement. 
 PART IV 
 MISCELLANEOUS 
 4.1 No Additional Obligations. Each Loan Party acknowledges
and agrees that the execution, delivery and performance of this Amendment shall not create (nor shall any Loan Party rely upon the existence of or claim or assert that there exists) any obligation of Lender to consider or agree to any other
amendment of or waiver or consent with respect to the Amended Loan Agreement or any other instrument or agreement to which Lender is a party (collectively, an “Additional Amendment” or “Consent”), and in the event
that Lender subsequently agrees to consider any requested Additional Amendment or Consent, neither the existence of this Amendment nor any other conduct of the Lender related hereto, shall be of any force or effect on the Lender’s consideration
or decision with respect to any such requested Additional Amendment or Consent, and Lender shall not have any obligation whatsoever to consider or agree to any such Additional Amendment or Consent. 

4.2 Waiver of Claims. In order to induce Lender to enter into this Amendment, each Loan Party hereby releases, remises, acquits
and forever discharges Lender and each of its employees, agents, representatives, consultants, attorneys, officers, directors, partners, fiduciaries, predecessors, successors and assigns, subsidiary corporations, parent corporations and related
corporate divisions (collectively, the “Released Parties”), from any and all actions, causes of action, judgments, executions, suits, debts, claims, demands, liabilities, damages and expenses of any and every character, known or
unknown, direct or indirect, at law or in equity, of whatever nature or kind, whether heretofore or hereafter arising, for or because of any manner of things done, omitted or suffered to be done by any of the Released Parties prior to and including
the date of execution hereof, and in any way directly or indirectly arising out of any or in any way connected to this Amendment, the Amended Loan Agreement or the other Loan Documents (collectively, the “Released Matters”).
Notwithstanding anything to the contrary in this Section 4.2, any 

  
 6 

 
and all actions, causes of action, judgments, executions, suits, debts, claims, demands, liabilities, damages and expenses, known or unknown, direct or indirect, at law or in equity resulting
from Lender’s gross negligence or willful or intentional misconduct shall not be included in the definition of Released Matters. Each Loan Party hereby acknowledges that the agreements in this Section 4.2 are intended to be in full
satisfaction of all or any alleged injuries or damages arising in connection with the Released Matters. Each Loan Party hereby represents and warrants to Lender that it has not purported to transfer, assign or otherwise convey any right, title or
interest of such Loan Party in any Released Matter to any other Person and that the foregoing constitutes a full and complete release of all Released Matters. 
 4.3 Acknowledgments and Stipulations. In order to induce Lender to enter into this Amendment, each Loan Party acknowledges, stipulates and agrees that (a) all of the Obligations are absolutely
due and owing by such Loan Party to Lender without any defense, deduction, offset or counterclaim (and, to the extent such Loan Party had any defense, deduction, offset or counterclaim on the date hereof, the same is hereby waived by such Loan
Party); (b) the Loan Documents executed by such Loan Party are legal, valid and binding obligations of such Loan Party enforceable against such Loan Party in accordance with their respective terms, except as enforcement may be limited by
equitable principles or by bankruptcy, insolvency, reorganization, moratorium, or similar laws relating to or limiting creditors’ rights generally; (c) the Liens granted by Borrower to Lender in the Collateral are valid and duly perfected,
first priority Liens, subject only to Permitted Liens; (d) each of the recitals contained at the beginning of this Amendment is true and correct; and (e) prior to executing this Amendment, such Loan Party consulted with and had the benefit
of advice of legal counsel of its own selection and has relied upon the advice of such counsel, and in no part upon the representation of Lender or any counsel to Lender concerning the legal effects of this Amendment or any provision hereof.

 4.4 Cross-References. References in this Amendment to any Part or are, unless otherwise specified, to such Part or of
this Amendment. 
 4.5 References in Other Credit Documents. At such time as this Amendment shall become effective
pursuant to the terms of Section 3.1, all references in the Existing Loan Agreement (including without limitation the Schedules thereto) to the “Agreement”, and all references in the other Loan Documents to the “Loan
Agreement” or “Loan and Security Agreement”, shall be deemed to refer to the Amended Loan Agreement. 
 4.6
Representations and Warranties of Loan Parties. Each Loan Party hereby represents and warrants that (a) the representations and warranties contained in Section 5 of the Existing Loan Agreement (after giving effect to the amendments
contained herein) are correct in all material respects on and as of the date hereof as though made on and as of such date, except to the extent any such representations or warranties refer back to a specific earlier date, and then only as of such
date, and (b) no Default or Event of Default exists under the Existing Loan Agreement on and as of the date hereof. Without limitation of the preceding sentence, each Loan Party hereby expressly re-affirms the validity, effectiveness and
enforceability of each Loan Document to which it is a party (in each case, as the same may be modified by the terms of this Amendment). 
 4.7 Counterparts. This Amendment may be executed in any number of counterparts each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one
and the same agreement. Delivery of an executed counterpart of this Amendment by telefacsimile (or in pdf or similar format via electronic mail) shall be equally as effective as delivery of an original executed counterpart of this Amendment. Any
party delivering an executed counterpart of this Amendment by telefacsimile also shall deliver an original executed counterpart of this Amendment but the failure to deliver an original executed counterpart shall not affect the validity,
enforceability, and binding effect of this Amendment. 

  
 7 

 4.8 Incorporation of Terms. THIS AMENDMENT SUPPLEMENTS, AND FORMS A PART OF, THE
EXISTING LOAN AGREEMENT, BUT (FOR THE AVOIDANCE OF DOUBT) THE PARTIES HERETO IN ANY EVENT SPECIFICALLY AGREE (WITHOUT LIMITATION OF THE FIRST PART OF THIS SENTENCE) THAT THE PROVISIONS OF SECTION 13 OF THE EXISTING LOAN AGREEMENT APPLY TO THIS
AMENDMENT AS IF SUCH PROVISIONS WERE INCORPORATED HEREIN. 
 [The remainder of this page is intentionally left blank.]

  
 8 

 Each of the parties hereto has caused a counterpart of this Amendment to be duly executed
and delivered as of the date first above written. 
  

			
	MARLIN RECEIVABLES CORP.,
	a Nevada corporation, as Borrower
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	MARLIN LEASING CORPORATION,
	a Delaware corporation, as Servicer and a Guarantor
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	MARLIN BUSINESS SERVICES CORP.,
	a Pennsylvania corporation, as Parent and a Guarantor
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	WELLS FARGO CAPITAL FINANCE, LLC,
	a Delaware limited liability company, as Lender
		
	By:	 	  

	Name:	 	  

	Title:Partial Lease Termination Agreement

 Exhibit 10.1 
 O Y S T E R   P O I N T   M A R I N A   P L A Z A 
 Partial Lease Termination Agreement 
 THIS PARTIAL LEASE TERMINATION AGREEMENT
(“Agreement”) is made and entered into as of June 27, 2012, by and between KASHIWA FUDOSAN AMERICA, INC., a California corporation (“Landlord”) and
TRANSCEPT PHARMACEUTICALS, INC., a Delaware corporation fka Novacea, Inc. (“Tenant”). 
 Recitals

 A. Landlord or its predecessor and Tenant or its predecessor have heretofore entered into that certain lease dated as of
May 15, 2007 (the “Lease”) for premises described as Suite 200 (the “Premises”), initially containing approximately 25,288 rentable square feet, in the building located at 400 Oyster Point Boulevard, South San Francisco,
California (the “Building”), which forms part of the office building complex commonly known as Oyster Point Marina Plaza (the “Complex”). 
 B. The Lease has not heretofore been amended or assigned. 
 C. The Term of the
Lease commenced on November 1, 2007, and in the absence of this Agreement would have expired on October 31, 2012. 

D. The parties mutually desire to terminate the Lease as to a portion of the Premises, all on and subject to the terms and conditions
hereof. 
 Agreement 
 Now therefore, in consideration of the mutual terms and conditions herein contained and of other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties
agree as follows: 
 1 EFFECTIVE DATE. This Agreement shall be effective as an executory contract
between the parties immediately upon their execution and delivery of the Agreement to each other. The partial termination of the Lease provided for hereunder shall become effective at 11:59 p.m. on June 30, 2012 (the “Effective
Date”). Except as expressly modified under this Agreement, the Lease shall remain in full force and effect through its Expiration Date. 

2 TERMINATION. Notwithstanding anything to the contrary in the Lease, the Term of the Lease shall be deemed to have
terminated and expired on the Effective Date with respect to a portion of the Premises comprising approximately 18, 368 rentable square feet of space only as depicted on Exhibit C attached hereto and incorporated herein by
reference (the “Released Space”); provided, however, that if Tenant shall violate any material provisions hereof, or if Tenant’s representations herein shall be false in any material respect, Landlord shall have the right to declare
such termination null and void and to reinstate the Lease, in addition to, and not in lieu of, any other rights or remedies that may be available to Landlord. The Released Space shall be deemed to have been surrendered by Tenant on the Effective
Date, but Tenant shall nevertheless fully comply with all obligations under the Lease with respect to the Released Space through the Effective Date, including those provisions relating to the condition of the Premises and removal of Tenant’s
personal property upon expiration of the Lease. 
 2.1 Condition Precedent. This Agreement is expressly
conditioned upon Landlord’s ability to enter into a two-year lease agreement with a new tenant for the majority of the Released Space. If 

  
 Oyster
Point Marina Plaza Lease Termination Agreement 
 Kashiwa Fudosan America, Inc. :: Transcept Pharmaceuticals, Inc.

  

					
		  	page 1 of 5	  	[Suite 200, 25,288 rsf]

 
Landlord fails for any reason to enter into such a new lease agreement for the Released Space on or before the Effective Date, this Agreement shall be null and void and of no further force or
effect, and the Lease shall continue in effect through its Expiration Date fully as though the parties had never executed and delivered this Agreement to each other. 
 2.2 Sublease Termination. Tenant acknowledges that BiPar Sciences (“BiPar”) currently occupies the Released Space under the terms of a sublease agreement between Tenant and BiPar
dated as of March 24, 2009. Tenant further understands and acknowledges that no privity of contract or estate exists between Landlord and BiPar and therefore agrees that Tenant shall be responsible, at no charge or cost to Landlord, for
terminating the BiPar sublease and causing BiPar to vacate the Released Space on or before the Effective Date of this Agreement (subject to the provisions of ¶ 3.2 below) in order to effectuate the partial termination of the Lease provided
for hereunder. Notwithstanding anything to the contrary herein or in the Lease, Tenant shall not be required to restore any improvements or remove any telecom wiring in the Released Space in connection with the partial termination of the Lease
effected hereunder. 
 2.3 Continuation of Bay Area Bioscience Association Sublease. Tenant acknowledges that a
portion of the Premises comprising approximately 6,920 rentable square feet of space depicted on Exhibit C attached hereto (the “BayBio Space”) is currently subleased to Bay Area Biosciences Association
(“BayBio”) under the terms of a sublease dated as of June 11, 2009. Upon the Effective Date the BayBio Space shall be separately demised and denominated as Suite 221. Tenant agrees that the Lease with respect to the BayBio Space
shall continue in full force and effect through the Expiration Date of the Lease. Notwithstanding anything to the contrary herein or in the Lease, Tenant shall not be required to restore any improvements or remove any telecom wiring in the BayBio
Space upon the expiration of the Term of the Lease. 
 3 DISPOSITION OF PROPERTY.
Notwithstanding anything to the contrary contained in the Lease, it is understood and agreed that Tenant shall remove from the Released Space the improvements, fixtures, and equipment described in Exhibit A, if such an Exhibit A is attached
hereto. Tenant shall leave upon the Released Space all other improvements, furniture, fixtures, and equipment, including without limitation those items described in Exhibit B (collectively “Tenant’s FFE”), and upon the
Effective Date Tenant hereby transfers all right, title, and interest in such items to Landlord on an “as-is, where-is” basis, fully as though by bill of sale, and represents and warrants that Landlord and its successors and assigns shall
hold and enjoy the same free of claims by any other party. 
 3.1 Tenant’s Furniture, Fixtures, &
Equipment. In consideration of Landlord’s agreement to permit the partial termination of the Lease effected under this Agreement, Tenant agrees to transfer all its right, title, and interest in Tenant’s FFE to Landlord by bill of sale
on the Effective Date at no charge to Landlord. 
 3.2 Temporary Use by Subtenant. Notwithstanding anything to the
contrary herein, Landlord agrees that BiPar shall be allowed to continue to utilize for its current purpose on a temporary basis in portion of the Released Space constituting the new Suite 212 (depicted on Exhibit C attached
hereto) that will be created on the Effective Date through July 31, 2012, at no charge to either Tenant or BiPar. 

  
 Oyster
Point Marina Plaza Lease Termination Agreement 
 Kashiwa Fudosan America, Inc. :: Transcept Pharmaceuticals, Inc.

  

					
		  	page 2 of 5	  	[Suite 200, 25,288 rsf]

 4 PAYMENTS AND AMENDMENTS. Tenant shall
continue to pay all rentals and other charges under the Lease through the Effective Date, all of which shall be prorated on a per diem basis. Any undetermined charges may be billed to Tenant when determined (and Tenant’s obligation to pay the
same shall survive termination of the Lease), or Landlord may reasonably estimate such charges and require that Tenant pay the same within thirty (30) days after Landlord bills the same, subject to adjustment after the actual charges have been
determined. Landlord and Tenant agree that Tenant shall not be required to pay a lease termination fee in connection with the partial termination of the Lease agreed hereunder. 
 4.1 Amendment of Base Rent. From and after the Effective Date, the Base Rent shall equal the product of the Base Rent as set forth in the Lease, and a fraction the numerator of which is the
number of rentable square feet in the BayBio Space, and the denominator of which is the number of rentable square feet in the Premises (the “Leased Space Ratio”). 
 4.2 Amendment of Additional Rent. From and after the Effective Date, the definition of “Tenant’s Pro Rata Share” in § 4.2(d) of the Lease shall be modified such that
references to the “Premises” shall be references to the BayBio Space, and the Tenant’s Pro Rata Share set forth in the Table in the Lease shall be adjusted accordingly. 
 5 MUTUAL RELEASES. In consideration of Landlord’s releasing Tenant from the obligation to pay the balance of the rentals due under the Lease with respect
to the Released Space and executing this Agreement, and in consideration of Tenant’s agreement to pay the amounts described in ¶ 4 above and of the representations and other agreements herein contained, Landlord and Tenant hereby
release and forever discharge each other and their respective partners, officers, directors, agents, trustees, beneficiaries, and employees of and from any and all claims, liabilities, acts, damages, demands, rights of action, and causes of action
which each party ever had, now has, or in the future may have against the other arising from or in any way connected with the Released Space under the Lease or Landlord’s management or operation of the Building or Complex with respect to the
Released Space, except for those obligations and liabilities contained herein or reinstated pursuant to the provisions hereof or under the Lease with respect to the BayBio Space. This release is intended as a full settlement and compromise of each,
every, and all claims and liabilities of every kind and nature. Both parties expressly waive any and all rights which they may have under § 1542 of the Civil Code of the State of California (or such similar statutes), which provides as
follows: 
 A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT
TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR. 
 Landlord and Tenant understand and agree that by execution of this Agreement, the other party and its partners, officers, directors, agents, trustees, beneficiaries, and employees do not admit any
liability of any nature whatsoever. This Agreement is made entirely as a compromise and for the purpose of terminating the Term of the Lease with respect to a portion of the Premises and settling and extinguishing the respective claims, acts,
damages, demands, rights of action, or causes of action of Landlord and Tenant with respect to the Released Space under the Lease. 
 6
WARRANTIES AND REPRESENTATIONS. Each party represents to the other that it has full power and authority to execute this Agreement. Each party represents to the other that, except as recited
herein, it has not made any assignment, sublease, transfer, conveyance, or other disposition of the Lease or any interest in the Lease or the Released Space and that it has no knowledge of any existing or threatened claim, demand, obligation,
liability, action, or cause of action arising from or in any manner connected with the Lease or the Released Space by any other party. Tenant represents that Tenant has not at any time done or suffered, and will not do or suffer, any act or thing
whereby the Released Space or any part thereof are or may be in any way charged, affected, or covered by any lien or claim and shall indemnify, defend, protect, and hold Landlord harmless from all liabilities, claims, expenses, damages, or costs
arising from the same, including (without limitation) attorneys’ fees and costs. 

  
 Oyster
Point Marina Plaza Lease Termination Agreement 
 Kashiwa Fudosan America, Inc. :: Transcept Pharmaceuticals, Inc.

  

					
		  	page 3 of 5	  	[Suite 200, 25,288 rsf]

 7 HOLDING OVER. Tenant shall comply with § 26.1 of
the Lease in the event that Tenant (or any subtenants or other occupants of the Released Space) retains possession of the Released Space or any part thereof after the Effective Date (adjusted to apply to the Rent applicable to the Released Space).
The foregoing provisions shall not serve to extend the Term, although Tenant shall be bound to comply with all provisions of the Lease until Tenant vacates the Released Space. 
 8 NOTICES. Any notice given by any party to another party hereto shall be by certified or registered mail, return receipt requested, postage prepaid, to such other party at
the address given below or such other address as such other party may from time to time designate in writing to the other parties in accordance with these provisions. The addresses set forth below shall supersede any addresses for notices set forth
in the Lease or in the Amendment. Any such notice shall be deemed given when placed in the United States mails with sufficient postage prepaid. 
  

			
	Landlord:	  	KASHIWA FUDOSAN AMERICA, INC.
		  	c/o Cushman & Wakefield of California, Inc., Agent
		  	Attn: Oyster Point Asset Manager
		  	400 Oyster Point Boulevard, Suite 117
		  	South San Francisco, CA 94080
		
	Tenant:	  	TRANSCEPT PHARMACEUTICALS, INC.
		  	Attn: Dennie W. Dyer, Vice President Operations
		  	1003 West Cutting Boulevard, Suite 110
		  	Point Richmond, CA 94804

 9 DEFINED TERMS. Terms used herein that are defined in the Lease or the
Amendment shall have the meanings therein defined, unless a different definition is set forth in this Agreement. In the event of any conflict between the provisions of the Lease, the Amendment and/or this Agreement, the terms of this Agreement shall
prevail. 
 10 SURVIVAL. Warranties, representations, agreements, and obligations contained in this Agreement shall
survive the execution and delivery of this Agreement and shall survive any and all performances in accordance with this Agreement. 
 11
COUNTERPARTS. This Agreement may be executed in any number of counterparts, which each severally and all together shall constitute one and the same Agreement. 
 12 ATTORNEYS’ FEES. If any party obtains a judgment against any other party or parties by reason of breach of this Agreement, reasonable attorneys’
fees and costs as fixed by the court shall be included in such judgment against the losing party or parties. 
 13
SUCCESSORS. This Agreement and the terms and provisions hereof shall inure to the benefit of and be binding upon the heirs, successors, and assigns of the parties. 
 14 GOVERNING LAW. This Agreement shall be construed and enforced in accordance with the laws of the State of California. 

15 LANDLORD’S REPRESENTATIVE. Tenant acknowledges and agrees that, in executing this
Lease, TAK Development, Inc., a California corporation, is acting solely in its capacity as Landlord’s authorized attorney-in-fact. TAK Development, Inc. is not acquiring or assuming any legal liability or obligation to any other party
executing this Lease, and any claim or demand of any such other party arising under or with respect to this Lease shall be made and enforced solely against Landlord. 

  
 Oyster
Point Marina Plaza Lease Termination Agreement 
 Kashiwa Fudosan America, Inc. :: Transcept Pharmaceuticals, Inc.

  

					
		  	page 4 of 5	  	[Suite 200, 25,288 rsf]

 16 WHOLE AGREEMENT. The mutual obligations of the parties as
provided herein are the sole consideration for this Agreement, and no representations, promises, or inducements have been made by the parties other than as appear in this Agreement. This Agreement may not be amended except in writing signed by all
the parties. 
 In witness whereof, the parties have executed this Agreement as of the date first above written. 

 

															
			
	Landlord:	 		 	Tenant:
			
	KASHIWA FUDOSAN AMERICA, INC., a California corporation	 		 	TRANSCEPT PHARMACEUTICALS, INC., a Delaware corporation fka Novacea, Inc.
							
		 	By:	 	TAK Development, Inc., a California corporation	 		 		 	By:	 	 /s/ Thomas P. Soloway

		 	Its:	 	Attorney-in-Fact	 		 		 		 	 Thomas P. Soloway

          name typed]

								
		 		 	By:	 	 /s/ Toru Iwai
	 		 		 	Its:	 	EVP, COO
		 		 		 	 Toru Iwai, Vice President

6/27/2012
	 		 		 		 	

  
 Oyster
Point Marina Plaza Lease Termination Agreement 
 Kashiwa Fudosan America, Inc. :: Transcept Pharmaceuticals, Inc.

  

					
		  	page 5 of 5	  	[Suite 200, 25,288 rsf]

 [Exhibit A] 
 [PROPERTY TO BE REMOVED FROM THE RELEASED SPACE] 
 All personal property
belonging to the subtenant currently occupying the Released Space. 

 Exhibit B 
 [PROPERTY TO BE LEFT IN THE RELEASED SPACE] 
  

									
	 Exhibit B to Partial Termination with Transcept
	   
	  		  	
	 Transcept Furniture List
	  				  		  	
	 Suite 200, 400 Oyster Point Blvd.
	  				  		  	
	 Prepared: June 19, 2012
	  				  		  	
	 	  	Total	 	  	 	  	 
	 General Office Area
	  				  		  	
	 Cubicles in Open Area
	  	 	17	  	  		  	
	 Desks in Private Offices
	  	 	30	  	  		  	
	 Chairs (rolling)
	  	 	78	  	  		  	
	 Chairs (guest)
	  	 	79	  	  		  	
	 Small Conference Tables
	  	 	10	  	  		  	
	 White Boards
	  	 	36	  	  		  	
	 High File Cabinet (metal)
	  	 	10	  	  		  	
	 Low File Cabinets (metal)
	  	 	34	  	  		  	
	 Tall Cabinets (wood)
	  	 	4	  	  		  	
	 Book Shelves
	  	 	19	  	  		  	
	 Small Refrigerators
	  	 	3	  	  		  	
				
	 Reception Area
	  				  		  	
	 Built-in Reception Desk
	  	 	1	  	  		  	
	 Sofa
	  	 	1	  	  		  	
	 Coffee Table
	  	 	1	  	  		  	
	 Cabinet
	  	 	1	  	  		  	
	 Small End Table
	  	 	1	  	  		  	
				
	 Kitchen
	  				  		  	
	 Refrigerator
	  	 	1	  	  		  	
	 Metal racks
	  	 	4	  	  		  	
	 Small Tables
	  	 	7	  	  		  	
	 Chairs
	  	 	23	  	  		  	
				
	 Innowave Water Chiller
	  	 	1	  	  		  	

											
	 Storage Rooms
	  				  				  	
	 Shelves
	  	 	13	  	  				  	
	 Desks
	  	 	2	  	  				  	
	 Racks
	  	 	8	  	  				  	
	 Storage Cabinets
	  	 	4	  	  				  	
				
	 Main Conference Rooms
	  				  				  	
	 Large Conference Table
	  	 	1	  	  				  	
	 Leather Chairs
	  	 	15	  	  				  	
	 Sharp Flat Screen Monitor
	  	 	1	  	  				  	
	 Epson Projector
	  	 	1	  	  				  	
	 Glass White Board
	  	 	1	  	  				  	
				
	 Small Conference Rooms
	  				  				  	
	 Conference Room Tables
	  	 	3	  	  				  	
	 Epson Projectors
	  	 	2	  	  				  	
	 (Chairs and white boards included in total count)
	  				  				  	
				
	 Small Conference Rooms
	  				  				  	
	 Rolling Server Cabinet
	  	 	1	  	  				  	
	 Server Racks
	  	 	2	  	  				  	
	 Patch Panel
	  	 	1	  	  				  	
	 White Board
	  	 	1	  	  				  	
	 Metal Cabinet
	  	 	1	  	  				  	
				
	 Sanofi Shall Remove
	  				  				  	
	 Kitchen and Miscellaneous Equipment
	  				  				  	
	 Microwave
	  				  	 	1	  	  	Belongs to Sanofi
	 Toaster over
	  				  	 	1	  	  	Belongs to Sanofi
	 Toaster
	  				  	 	1	  	  	Belongs to Sanofi
	 Coffee Makers
	  				  	 	2	  	  	Belongs to Sanofi
	 Printers
	  				  	 	7	  	  	Belongs to Sanofi
	 Cannon Copier
	  				  	 	1	  	  	Belongs to Sanofi
	 Open Area Furniture
	  				  				  	
	 Tables
	  				  	 	3	  	  	Belongs to Sanofi
	 Sofas
	  				  	 	2	  	  	Belongs to Sanofi
	 Glass tables
	  				  	 	2	  	  	Belongs to Sanofi

 Exhibit C

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}]]